ORMP News and Press, Oramed Pharmaceuticals Inc. From 11/03/21

Oramed Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules PR Newswire NEW YORK , Nov. 3, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. ("Oramed" or the "Company") (Nasdaq: ORMP) (TASE: ORMP) ( www.or...

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) traded today at a new 52-week high of $24.41. This new high was reached on below average trading volume as 319,000 shares traded hands, while the average 30-day volume is approximately 608,000 shares. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) def...

Oramed Pharmaceuticals (NASDAQ:ORMP) company Oravax Medical has received clearance from the South African Health Products Regulatory Authority to commence patient enrollment in the company's early-stage oral COVID-19 vaccine trial. "An oral COVID-19 vaccine would eliminate seve...

Oramed Announces Oravax's Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial PR Newswire NEW YORK , Oct. 29, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pha...

Giant pharma Merck's co-developed oral coronavirus drug with Ridgeback Biotherapeutics has raised interest in non-injected vaccine alternatives. The space was already occupied by Oramed, a clinical-stage biotech, whose oral vaccine is based on its POD technique, together with India's ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Given all the talk about the pandemic, the delta variant and everything else, it would be easy to believe that pharmaceutical stocks are doing well this year. But the fact is, according to the benchmark S&P Pharmaceutic...

Shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) traded today at $23.89, eclipsing its 52-week high. This new high was reached on below average trading volume as 319,000 shares traded hands, while the average 30-day volume is approximately 817,000 shares. Oramed Pharmaceuticals Inc. s...

Oramed to Present at Cantor Fitzgerald Virtual Global Healthcare Conference PR Newswire NEW YORK , Sept. 23, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP), (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on t...

Oramed's Phase 2 Oral Insulin NASH Trial Reaches Over 50% Enrollment PR Newswire NEW YORK , Sept. 15, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the ...

Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire NEW YORK , Sept. 9, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused...